Background: Alzheimer’s disease poses significant global health challenges, particularly as people increasingly turn to online platforms for health information in the digital era. Given the intricate nature of Alzheimer’s, it is imperative to evaluate the readability of online content. This study aims to assess the readability of information related to Alzheimer’s disease on reputable health websites.Method: We carefully selected websites based on authority and prevalence through Google, the most popular search engine. Utilizing the neutral term “Alzheimer’s” ensured a broader sample of websites. We identified common domains within the top ten search results and meticulously sorted and saved them. Texts were then extracted and cleaned using Microsoft Office Excel. To evaluate readability, we employed various readability formulas using Python. The Flesch Reading Ease Score (FRES), Flesch–Kincaid grade level (FKGL), Simple Measure of Gobbledygook (SMOG), Gunning Fog (GFOG), Coleman–Liau score (CL), automated readability index (ARI), and Linsear Write (LW) were utilized.Result: When comparing our readability results to the sixth‐grade level recommended by the American Medical Association and the National Institute of Health, we observed that the scores exceeded the recommended level. Findings from widely used internet resources revealed variations in readability scores across different websites. Notably, publicly accessible data related to Alzheimer’s disease tends to be presented at a higher reading level than recommended for general comprehension, carrying critical implications for patient education and health literacy within the Alzheimer’s context.Conclusion: Assessing the readability of online health information for Alzheimer’s disease is crucial to ensure accessibility and comprehension for diverse audiences. This study provides valuable insights into the readability landscape of reputable health websites, uncovering a potential gap between the complexity of information and the general public’s reading ability in the context of Alzheimer’s disease. Recognizing and addressing this gap is essential for enhancing patient education and empowerment, ultimately contributing to improved health outcomes in the realm of Alzheimer’s.
Background: Ectopic pregnancy occurs in about 1–2% of all pregnancies, with 95% implanting in the fallopian tubes. Hepatic implantation is one of the rarest and most dangerous forms of abdominal ectopic pregnancy. Its diagnosis is often delayed because of nonspecific symptoms, and it is also often difficult for routine ultrasound imaging to visualize ectopic pregnancy sites that are not in the pelvis. Since this type of pregnancy carries a risk of severe hemorrhage, early identification is crucial. Case: A 30-year-old woman, gravida 3 para 2, presented with a serum β-hCG of 66,408 mIU/mL, but no intrauterine pregnancy was detected on ultrasound imaging. At an outside facility, a laparoscopy was performed, which also failed to show a pelvic ectopic pregnancy. The patient then received her first dose of methotrexate and was subsequently transferred to a tertiary care center for further evaluation. MRI and liver ultrasound showed a 2.3 cm subcapsular lesion in segment 5 of the liver that was suspicious for a hepatic ectopic pregnancy. However, these imaging studies could not exclude a gestational trophoblastic disease or hepatic neoplasm. A dilation and curettage revealed no trophoblastic tissue. The patient next received two additional doses of methotrexate on hospital days 4 and 7 due to an inadequate decline in interval β-hCG; β-hCG levels declined gradually but steadily over several months until they became undetectable and indicated a successful medical treatment of her hepatic ectopic pregnancy. Conclusions: This case highlights the complex diagnostic and treatment challenges presented by a hepatic ectopic pregnancy. Multimodal imaging, serial monitoring of β-hCG levels, and the engagement of a multidisciplinary team were essential factors in achieving a safe, nonsurgical, and successful resolution of this condition. When a pregnancy of unknown location is suspected, extended imaging studies are critical tools for patient evaluation after initial imaging studies and laparoscopy are inconclusive.
Background: Non-invasive prenatal testing (NIPT) examines cell-free DNA (cfDNA) in maternal serum, which includes both maternal DNA and apoptotic placental DNA. The presence of multiple aneuploidies or widespread abnormal patterns of gains and losses across chromosomes in a structurally normal fetus has been linked to maternal cancer. Case Presentation: The patient was a 22-year-old G1P0 with a history of classical Hodgkin’s lymphoma in remission. Her NIPT collected at 14 weeks and 3 days was reported as a “no call”. A second NIPT at a different laboratory showed multiple chromosomal aneuploidies (trisomy 18, 21, and monosomy X) with normal fetal anatomy on ultrasound. The patient was asymptomatic and was referred to hematology–oncology specifically to address the concern that these NIPT results could be related to cancer recurrence. Imaging was deferred as she was already on an established surveillance protocol for her Hodgkin’s lymphoma. At 26 weeks of gestation, the patient presented with a cough and dyspnea. Chest x-ray raised concern for disease recurrence, and biopsy confirmed recurrent Hodgkin’s lymphoma. She received two cycles of ICE chemotherapy. Cesarean delivery at 34 weeks and 2 days was performed for non-reassuring fetal heart tones. She continued chemotherapy, followed by BEAM conditioning and autologous stem cell transplantation. Genetic testing of the neonate revealed a normal karyotype; the placenta karyotype yielded no interpretable results. Discussion and Conclusions: Certain patterns of abnormal NIPT results may be associated with maternal malignancy and warrant further investigation. The absence of standardized protocols for reporting such NIPT results can complicate timely interdisciplinary evaluation and treatment. However, diagnostic testing should be offered with a positive NIPT result, a no-call or test failure, and abnormal ultrasound results, even with a “low-risk” NIPT result.
Background: Alzheimer’s disease poses significant global health challenges, particularly as people increasingly turn to online platforms for health information in the digital era. Given the intricate nature of Alzheimer’s, it is imperative to evaluate the readability of online content. This study aims to assess the readability of information related to Alzheimer’s disease on reputable health websites.Method: We carefully selected websites based on authority and prevalence through Google, the most popular search engine. Utilizing the neutral term “Alzheimer’s” ensured a broader sample of websites. We identified common domains within the top ten search results and meticulously sorted and saved them. Texts were then extracted and cleaned using Microsoft Office Excel. To evaluate readability, we employed various readability formulas using Python. The Flesch Reading Ease Score (FRES), Flesch–Kincaid grade level (FKGL), Simple Measure of Gobbledygook (SMOG), Gunning Fog (GFOG), Coleman–Liau score (CL), automated readability index (ARI), and Linsear Write (LW) were utilized.Result: When comparing our readability results to the sixth‐grade level recommended by the American Medical Association and the National Institute of Health, we observed that the scores exceeded the recommended level. Findings from widely used internet resources revealed variations in readability scores across different websites. Notably, publicly accessible data related to Alzheimer’s disease tends to be presented at a higher reading level than recommended for general comprehension, carrying critical implications for patient education and health literacy within the Alzheimer’s context.Conclusion: Assessing the readability of online health information for Alzheimer’s disease is crucial to ensure accessibility and comprehension for diverse audiences. This study provides valuable insights into the readability landscape of reputable health websites, uncovering a potential gap between the complexity of information and the general public’s reading ability in the context of Alzheimer’s disease. Recognizing and addressing this gap is essential for enhancing patient education and empowerment, ultimately contributing to improved health outcomes in the realm of Alzheimer’s.